End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,647 KRW | +0.73% | +1.17% | -25.31% |
Business Summary
Number of employees: 130
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Ingredients
100.0
%
| - | - | 122,541 | 100.0 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
99.1
%
| 132,053 | 100.0 % | 121,409 | 99.1 % | -8.06% |
Overseas
0.9
%
| - | - | 1,133 | 0.9 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pil-Jun Park
CEO | Chief Executive Officer | 63 | 79-04-30 |
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 13-09-30 |
Yong-Ho Jung
CTO | Chief Tech/Sci/R&D Officer | 72 | 10-01-31 |
Sang-Chun Ahn
BRD | Director/Board Member | 61 | 13-09-30 |
Sales & Marketing | 55 | 13-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 13-09-30 |
Pil-Jun Park
CEO | Chief Executive Officer | 63 | 79-04-30 |
Sang-Chun Ahn
BRD | Director/Board Member | 61 | 13-09-30 |
Jung-Il Park
BRD | Director/Board Member | 54 | 14-03-20 |
Doo-Won Park
BRD | Director/Board Member | 69 | 13-10-13 |
Jong-Ryu Choi
BRD | Director/Board Member | 65 | 17-03-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,877,652 | 37,494,853 ( 48.77 %) | 0 | 48.77 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
PANGEN BIOTECH INC. 7.28% | 831,203 | 7.28% | 3,770,811 $ |
2,340,000 | 3.52% | 2,724,158 $ |
Company contact information
HWAIL PHARMACEUTICAL Co., Ltd.
57 Jeyakgongdan 3-gil Hyangnam-eup
18622, Hwaseong
+
http://www.hwail.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-25.31% | 79.13M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- A061250 Stock
- Company Hwail Pharmaceutical Co.,Ltd.